500 likes | 602 Views
Join Sophy Wong in this engaging session designed to enhance your presentation skills through effective visual design. By the end of the workshop, participants will be able to discuss and practice three core visual presentation design principles: simplicity, repetition, and alignment. You'll evaluate existing slides to recommend improvements for higher visual impact and create your own high-impact slide for powerful presentations. Elevate your presentation game and captivate your audience with powerful visuals!
E N D
October E-learn Call: Visual Design for Powerful Presentations Sophy Wong (East Bay AETC)
Objectives By the end of this session, participants will be able to: • Discuss and practice using 3 visual presentation design principles • Evaluate 2 example presentation slides and recommend 2 ways to increase their visual impact • Create your own awesome, high-impact slide
for Powerful Presentations! Sophy Wong, MD
bullet • point • makeover
Cohort study data show survival benefit if ART initiated at CD4 count >500 cells/µL Earlier ART may prevent HIV-related end organ damage; deferred ART may not reliably repair damage acquired earlier Increasing evidence of direct HIV effects on various end organs and indirect effects via HIV-associated inflammation End organ damage occurs at all stages of infection Potential Benefits of Early Therapy (CD4 count >500 cells/µL) www.aidsetc.org
Potential decrease in risk of many complications, including: HIV-associated nephropathy Liver disease progression from hepatitis B or hepatitis C Cardiovascular disease Malignancies (AIDS defining and non-AIDS defining) Neurocognitive decline Blunted immunological response owing to ART initiation at older age Persistent T-cell activation and inflammation Potential Benefits of Early Therapy (CD4 count >500 cells/µL) (2) www.aidsetc.org
Prevention of sexual and bloodborne transmission of HIV Prevention of mother-to-child transmission of HIV Potential Benefits of Early Therapy (CD4 count >500 cells/µL) (3) www.aidsetc.org
ARV-related toxicities Drug resistance Nonadherence to ART Cost Potential Limitations of Early Therapy (CD4 count >500 cells/µL) www.aidsetc.org
When to start -adherence OIs -drug toxicity -resistance -lack of options +stay healthy transmission ↑CD4
Percentage of Newly Reported HIV (non-AIDS) Cases By Race/Ethnicity, Alameda County 2006-2010 Source: Centers for Disease Control and Prevention (CDC). eHARS. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, [2006-2010].
CA hep C treatment algorithm:handout! Getty Images
start fresh & focus
Contact • Any questions about the presentation: • Sophy Wong: sophy.wong@ucsf.edu